• A+
• A+
• A+

Adjust font size

GuideWisdom™

This WisdomCard managed by: Kricel Abreu

Boehringer Ingelheim has informed the U.S. Food and Drug Administration that their Spiriva Handihaler may increase the risk of a stroke in those who use it. The risk was compared to patients who used a placebo.

Top Resources on Boehringer Inhalers

• NPR: Boehringer Inhaler May Raise Stroke Risk
• in-Pharma Technologist: Boehringer Sees Alternative to Spiriva Inhaler Device
• Associated Press: Boehringer Inhaler May Raise Stroke Risk
• Wall Street Journal: Boehringer Inhaler Might Pose Higher Stroke Risk, FDA Says
• dbTechno: Boehringer Reports Their Inhaler Increases Stroke Risk

Related WisdomCards

• Chronic Obstructive Pulmonary Disease (COPD)
• Inhalers and COPD
• Albuterol
• American Lung Association

User Recommended Links for Boehringer Inhalers

Are we missing any great links? Please Login or Register to be the first to add to this list of recommended links to help others and improve this WisdomCard.